To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

Among them, T-cell LGLL (T-LGLL) and NK-cell LGLL (NK-LGLL) are the most prominent. Due to overlapping morphological, clinical, and immunophenotypic characteristics, distinguishing these disorders ...

It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal ...

Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does not charge access fees for the use of NOG mice, which can otherwise range ...

The NK cells first are activated with cytokines ... and vice president and head of MD Anderson’s Institute for Cell Therapy Discovery & Innovation. Through the institute, Rezvani and her ...